From: The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it
Variables | Non-CHD | CHD | p |
---|---|---|---|
(n = 80) | (n = 120) | ||
Male (%) | 55.0 | 76.7 | 0.002 |
Age (years) | 51.34 ± 8.35 | 55.52 ± 10.04 | 0.002 |
BMI (kg/m2) | 26.19 ± 3.23 | 26.31 ± 3.50 | 0.697 |
Hypertension (%) | 47.5 | 58.3 | 0.191 |
Diabetes (%) | 11.3 | 19.2 | 0.247 |
TC (mmol/L) | 4.71 ± 0.80 | 4.49 ± 0.94 | 0.088 |
TG (mmol/L) | 1.62 ± 1.00 | 1.76 ± 0.84 | 0.079 |
HDL-c (mmol/L) | 1.24 ± 0.36 | 1.02 ± 0.23 | <0.001 |
LDL-c (mmol/L) | 3.03 ± 0.78 | 2.88 ± 0.82 | 0.199 |
ApoAI (mmol/L) | 1.48 ± 0.29 | 1.34 ± 0.24 | 0.001 |
ApoB (mmol/L) | 1.07 ± 0.22 | 1.16 ± 0.31 | 0.020 |
Glucose(mmol/L) | 5.64 ± 1.36 | 5.43 ± 1.56 | 0.327 |
HsCRP (mg/L) | 1.75 ± 1.72 | 3.66 ± 3.58 | <0.001 |
ApoCIII (mg/L) | 12.68 ± 3.74 | 11.97 ± 4.94 | 0.275 |
HDL-apoCIII (ug/mgHDL) | 21.00 ± 11.33 | 25.05 ± 12.98 | 0.024 |